News
AORT
44.59
-1.81%
-0.82
Weekly Report: what happened at AORT last week (1124-1128)?
Weekly Report · 12/01 10:06
Should Artivion’s (AORT) Upbeat Guidance and Insider Stock Sale Prompt a Closer Look From Investors?
Simply Wall St · 11/27 05:43
A Look at Artivion’s (AORT) Valuation Following Strong Q3 Results and Raised Full-Year Guidance
Simply Wall St · 11/25 14:30
Artivion’s SVP Cashes In on Major Stock Sales!
TipRanks · 11/25 02:04
Weekly Report: what happened at AORT last week (1117-1121)?
Weekly Report · 11/24 10:11
Oscar Health and Artivion Shares Are Soaring, What You Need To Know
Barchart · 11/21 20:08
Artivion Director Makes Significant Stock Sale!
TipRanks · 11/20 02:13
Top Executive Sells Thousands in Artivion Stock!
TipRanks · 11/19 02:13
Weekly Report: what happened at AORT last week (1110-1114)?
Weekly Report · 11/17 10:11
Is Artivion's Upgraded Outlook and Trial Launch Reshaping the Investment Case for AORT?
Simply Wall St · 11/16 17:22
Assessing Artivion (AORT) Valuation After Strong Earnings, Upbeat Guidance & New Innovation Milestone
Simply Wall St · 11/15 08:31
Artivion Executives Cash In: Massive Stock Sales Unveiled!
TipRanks · 11/15 02:03
Alger Weatherbie Specialized Growth Fund Q3 2025 Portfolio Update
Seeking Alpha · 11/12 10:09
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
Barchart · 11/12 00:38
Weekly Report: what happened at AORT last week (1103-1107)?
Weekly Report · 11/10 10:09
How Artivion’s Upgraded 2025 Outlook and Arcevo Trial Launch Will Impact AORT Investors
Simply Wall St · 11/08 20:37
Canaccord Genuity Maintains Artivion (AORT) Buy Recommendation
NASDAQ · 11/08 11:29
Artivion Inc. Reports Robust Earnings Amid Growth Challenges
TipRanks · 11/08 00:10
Artivion Price Target Raised to $51.00/Share From $50.00 by Canaccord Genuity
Dow Jones · 11/07 21:45
Artivion Is Maintained at Buy by Canaccord Genuity
Dow Jones · 11/07 21:45
More
Webull provides a variety of real-time AORT stock news. You can receive the latest news about Artivion, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AORT
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.